Search Results - "Baliu‐Piqué, C."

Three cases of solar urticaria successfully treated with omalizumab by Baliu-Piqué, C., Aguilera Peiró, P.

Get full text

Nail-patella syndrome: report of 11 pediatric cases by Figueroa-Silva, O., Vicente, A., Agudo, A., Baliu-Piqué, C., Gómez-Armayones, S., Aldunce-Soto, M.J., Inarejos Clemente, E.J., Navallas Irujo, M., Gutiérrez de la Iglesia, D., González-Enseñat, M.A.

“…Background Nail–patella syndrome (NPS) is an inherited disease produced by mutations in the LMX1B gene. It is characterized by fingernail dysplasia,…”
Get full text

Omalizumab for the treatment of chronic inducible urticaria in 80 patients by Exposito‐Serrano, V., Curto‐Barredo, L., Aguilera Peiro, P., Gómez Armayones, S., Serra‐Baldrich, E., Spertino, J., Bonfill Ortí, M., Figueras Nart, I., Melé‐Ninot, G., Baliu‐Piqué, C., Sala Cunill, A., Labrador‐Horrillo, M., Guilabert Vidal, A., Fernández Chico, N., Giménez‐Arnau, A.M.

Get full text

Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria by Curto‐Barredo, L., Spertino, J., Figueras‐Nart, I., Expósito‐Serrano, V., Guilabert, A., Melé‐Ninot, G., Cubiró, X., Bonfill‐Ortí, M., Garcias‐Ladaria, J., Villar, M., García‐Navarro, X., Bielsa‐Marsol, I., Vilavella, M., Aparicio, G., Baliu‐Piqué, C., Álvarez, A., Lamas‐Domenech, N., Duran‐Jordà, X., Serra‐Baldrich, E., Giménez‐Arnau, A.

Get full text

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy by Gil-Lianes, J., Mozas, P., Baumann, T., Combalia, A., Baliu-Piqué, C., García, A., Rovira, M., López-Guerra, M., Villamor, N., Colomer, D., Rozman, M., Esteve, J., Estrach, T.

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematodermic neoplasm usually involving the skin. In this retrospective case…”
Get full text

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Single-Center Experience. Clinical Characterization, Mutational Landscape, and Clinical Outcome of Patients Undergoing Hematopoietic Stem Cell Transplantation Intensive Therapy by Gil-Lianes, J., Mozas, P., Baumann, T., Combalia, A., Baliu-Piqué, C., García, A., Rovira, M., López-Guerra, M., Villamor, N., Colomer, D., Rozman, M., Esteve, J., Estrach, T.

“…Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a rare and aggressive hematodermic neoplasm usually involving the skin. In this retrospective case…”
Get full text

Papular Acantholytic Dyskeratosis of the Vulva in a Woman With Benign Familial Pemphigus by Baliu-Piqué, C, Iranzo, P

Get full text

Papular Acantholytic Dyskeratosis of the Vulva in a Woman With Benign Familial Pemphigus by Baliu-Piqué, C, Iranzo, P

Get full text

Superficial Temporal Artery Pseudoaneurysm by Pigem, R, Baliu-Piqué, C, Bennàssar, A

Get full text

Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab by Spertino, J, Curto Barredo, L, Rozas Muñoz, E, Figueras Nart, I, Gimenez Arnau, A, Serra Baldrich, E, Bonfill-Ortí, M, Expósito-Serrano, V, Guilabert, A, Melé Ninot, G, Villar Buil, M, Garcias Ladaria, J, García Navarro, X, Vilavella, M, Bielsa Marsol, I, Aparicio Ortiz, G, Baliu Piqué, C, Álvarez Abella, A, Lamas Domenech, N, Mascaró, J M, Gómez, S, Torné Gutiérrez, J I, Vicente Villa, A

“…BACKGROUND AND OBJECTIVEPivotal trials with omalizumab for treatment of chronic spontaneous urticaria (CSU) are generally run over 12 to 24weeks. However, in…”
Get full text

Algorithm for Treatment of Chronic Spontaneous Urticaria with Omalizumab by Spertino, J., Curto Barredo, L., Rozas Muñoz, E., Figueras Nart, I., Serra Baldrich, E., Bonfill-Ortí, M., Expósito-Serrano, V., Guilabert, A., Melé Ninot, G., Villar Buil, M., Garcias Ladaria, J., García Navarro, X., Vilavella, M., Bielsa Marsol, I., Aparicio Ortiz, G., Baliu Piqué, C., Álvarez Abella, A., Lamas Domenech, N., Mascaró, J.M., Gómez, S., Torné Gutiérrez, J.I., Vicente Villa, A., Gimenez Arnau, A.

“…Pivotal trials with omalizumab for treatment of chronic spontaneous urticaria (CSU) are generally run over 12 to 24weeks. However, in clinical practice, many…”
Get full text

Superficial Temporal Artery Pseudoaneurysm by Pigem, R, Baliu-Piqué, C, Bennàssar, A

Get full text

Dermatosis neutrofílica de las manos (Sweet de las manos) asociada a artritis reumatoide by Baliu-Piqué, Carola, Nogués-Antich, Elena, Cucurell-Palomas, Marta, Grados, Dolors

Get full text

Three cases of solar urticaria successfully treated with omalizumab by Baliu-Piqué, C, Aguilera Peiró, P

Get full text